2m 2m 2m 2m 2m 2m 2m
Innospec (IOSP)
NASDAQ
$81.93-$0.54 (-0.65%)
Price as of Jun 23, 2026 4:10 PM EDT- $2.0BMarket Cap
- 0.98%1-Year Change
- Specialty ChemicalsIndustry
Innospec (IOSP)
$81.93-$0.54 (-0.65%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.8B -3.65% | 1.8B -5.31% | 1.9B -0.76% | 2.0B +32.38% | |
Cost of Revenue | 1.3B -1.30% | 1.3B -4.07% | 1.4B -1.40% | 1.4B +31.33% | |
Gross Profit | 492.4M -9.30% | 542.9M -8.15% | 591.1M +0.75% | 586.7M +34.90% | |
Sales and Marketing Expense | 285.1M -9.20% | 314.0M -19.03% | 387.8M +7.51% | 360.7M +34.99% | |
Research and Development Expense | -51.0M +6.69% | -47.8M +14.63% | -41.7M +7.75% | -38.7M +3.48% | |
Depreciation and Amortization Expense | 43.6M +0.23% | 43.5M +10.69% | 39.3M -2.00% | 40.1M -6.09% | |
Total Operating Expenses | 362.9M -0.58% | 365.0M -15.02% | 429.5M +7.54% | 399.4M +31.90% | |
Operating Profit | 129.5M -27.21% | 177.9M +10.09% | 161.6M -13.72% | 187.3M +41.79% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | 0 N/A | 0 N/A | 0 +100.00% | -1.1M -26.67% | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 +100.00% | -1.1M -26.67% | |
Total Nonoperating Income and Expense | -600,000 -106.25% | 9.6M -8.57% | 10.5M +756.25% | -1.6M -142.11% | |
Income before Taxes | 138.1M +235.19% | 41.2M -76.38% | 174.4M -5.53% | 184.6M +37.35% | |
Income Taxes | 21.5M +283.93% | 5.6M -84.14% | 35.3M -31.59% | 51.6M +24.94% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 116.6M +227.53% | 35.6M -74.41% | 139.1M +4.59% | 133.0M +42.86% | |
Net Income from Continuing Operations Applicable to Common | 138.1M +235.19% | 41.2M -76.38% | 174.4M -5.53% | 184.6M +37.35% | |
Basic EPS and Net Income | 4.69 +227.97% | 1.43 -74.46% | 5.60 +4.28% | 5.37 +42.06% | |
Diluted EPS and Net Income | 4.67 +228.87% | 1.42 -74.46% | 5.56 +4.51% | 5.32 +41.87% | |
Basic Weighted Average Shares | 24.9M -0.21% | 24.9M +0.33% | 24.9M +0.26% | 24.8M +0.57% | |
Diluted Weighted Average Shares | 25.0M -0.50% | 25.1M +0.39% | 25.0M +0.16% | 25.0M +0.52% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 292.5M +1.14% | 289.2M +41.97% | 203.7M +38.48% | 147.1M +3.74% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 292.5M +1.14% | 289.2M +41.97% | 203.7M +38.48% | 147.1M +3.74% | |
Total Current Assets | 1.0B +5.02% | 956.6M +8.00% | 885.7M +1.50% | 872.6M +19.85% | |
Accumulated Depreciation | 426.1M +24.48% | 342.3M +5.65% | 324.0M +11.11% | 291.6M +7.60% | |
Property and Plant and Equipment and Net | 286.1M +6.08% | 269.7M +0.52% | 268.3M +21.46% | 220.9M +3.03% | |
Total Long-Term Assets | 8.7M +123.08% | 3.9M -37.10% | 6.2M -12.68% | 7.1M +42.00% | |
Total Assets | 1.8B +5.63% | 1.7B +1.60% | 1.7B +6.47% | 1.6B +2.09% | |
Income Taxes Payable | 24.4M -43.39% | 43.1M -9.64% | 47.7M -27.29% | 65.6M -31.02% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Total Current Liabilities | 360.1M -3.04% | 371.4M -0.03% | 371.5M -8.45% | 405.8M +20.56% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 8.8M +109.52% | 4.2M +82.61% | 2.3M +64.29% | 1.4M 0.00% | |
Total Liabilities | 499.5M -3.68% | 518.6M -7.03% | 557.8M -0.98% | 563.3M +56.60% | |
Retained Earnings | 1.1B +7.24% | 1.0B -0.31% | 1.0B +11.25% | 924.2M +12.31% | |
Total Stockholders Equity | 1.3B +9.49% | 1.2B +5.59% | 1.1B +10.51% | 1.0B +0.54% | |
Total Shares Outstanding | 29.6M 0.00% | 29.6M 0.00% | 29.6M 0.00% | 29.6M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | 138.3M -25.04% | 184.5M -11.00% | 207.3M +153.73% | 81.7M -12.34% | |
Capital Expenditures | 50.3M +21.50% | 41.4M -33.33% | 62.1M +56.82% | 39.6M +1.28% | |
Cash from Investing Activities | -75.1M +21.13% | -62.0M -44.54% | -111.8M +165.56% | -42.1M +16.30% | |
Dividends Paid | 42.4M +9.28% | 38.8M +10.54% | 35.1M +10.73% | 31.7M +10.07% | |
Cash from Financing Activities | -63.9M +81.02% | -35.3M -9.49% | -39.0M +15.73% | -33.7M +68.50% | |
Financials Ratio | |||||
Gross Margin | 27.69% -5.86% | 29.42% -3.01% | 30.33% +1.52% | 29.88% +1.91% | |
Operating Margin | 7.28% -24.45% | 9.64% +16.25% | 8.29% -13.06% | 9.54% +7.11% | |
Return on Assets | 6.54% +216.05% | 2.07% -75.38% | 8.40% +0.27% | 8.38% +33.57% | |
Return on Equity | 9.19% +204.43% | 3.02% -76.29% | 12.73% -0.90% | 12.85% +36.40% | |
Revenue Growth | -3.65% -31.16% | -5.31% +599.24% | -0.76% -102.34% | 32.38% +33.07% | |
Current Ratio | 2.79 +8.31% | 2.58 +8.04% | 2.38 +10.87% | 2.15 -0.59% | |
Cash Ratio | 0.81 +4.31% | 0.78 +42.02% | 0.55 +51.26% | 0.36 -13.96% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow